Farmak, a leader of the domestic pharmaceutical market, has launched an electronic trading platform for potential suppliers of materials, equipment, and services. The resource is located at tenders.farmak.ua.
The electronic trading platform contains current information on tenders conducted by Farmak, conditions of participation and a list of documents to be submitted. It also enables to submit an electronic application for tender participation.
Sergiy Bryzhytsky, Deputy CFO, Farmak, says, “Farmak strives to organize its activities in such a way as to implement the most optimal solutions for products manufacturing and sales. This task can be solved only through cooperation with reliable and highly professional companies supplying materials, equipment, works, and services.
The electronic trading platform will provide open, convenient, and easy access to information, and this, in its turn, is one of the key requirements to competitive bidding, that results in guaranteed quality and optimal value of our medicinal products”.
Whether the refined processes can promote developing medicinal products? Yes, as far as the new innovative centre of Farmak as the Ukrainian pharmaceutical market leader is concerned. The Company intends to improve its operations as much as possible, provide personnel with comfortable office space, but most importantly to expand the capabilities of its R&...
Filya Zhebrovska, co-owner and Chairman of the Supervisory Board of the pharmaceutical company Farmak, has been included in the rating of the most influential women of 2021 traditionally published by Focus magazine at the end of June. When the editors compiled a list of candidates whose words and deeds were the most important and the […]
25 best corporate social responsibility (CSR) programs were presented in the ranking published by Vlast Deneg (The Power of Money) magazine. The magazine’s experts studied the companies’ cases and selected the leaders, i.e. the companies that have implemented the most effective and successful programs in 2020-2021. Data from open sources, media reports and e...